Development of a platform process for the production and purification of single-domain antibodies
- Autores
- Crowell, Laura E.; Goodwine, Chaz; Sosa Holt, Carla Solange; Rocha, Lucia; Vega, Celina Guadalupe; Rodriguez, Sergio A.; Dalvie, Neil C.; Tracey, Mary K.; Puntel, Mariana; Wigdorovitz, Andrés; Parreño, Gladys Viviana; Love, Kerry R.; Cramer, Steven M.; Love, J. Christopher
- Año de publicación
- 2021
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Single-domain antibodies (sdAbs) offer the affinity and therapeutic value of conventional antibodies, with increased stability and solubility. Unlike conventional antibodies, however, sdAbs do not benefit from a platform manufacturing process. While successful production of a variety of sdAbs has been shown in numerous hosts, purification methods are often molecule specific or require affinity tags, which generally cannot be used in clinical manufacturing due to regulatory concerns. Here, we have developed a broadly applicable production and purification process for sdAbs in Komagataella phaffii (Pichia pastoris) and demonstrated the production of eight different sdAbs at a quality appropriate for nonclinical studies. We developed a two-step, integrated purification process without the use of affinity resins and showed that modification of a single process parameter, pH of the bridging buffer, was required for the successful purification of a variety of sdAbs. Further, we determined that this parameter can be predicted based only on the biophysical characteristics of the target molecule. Using these methods, we produced nonclinical quality sdAbs as few as 5 weeks after identifying the product sequence. Nonclinical studies of three different sdAbs showed that molecules produced using our platform process conferred protection against viral shedding of rotavirus or H1N1 influenza and were equivalent to similar molecules produced in Escherichia coli and purified using affinity tags.
Fil: Crowell, Laura E.. Massachusetts Institute of Technology; Estados Unidos
Fil: Goodwine, Chaz. Rensselaer Polytechnic Institute; Estados Unidos
Fil: Sosa Holt, Carla Solange. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Instituto Nacional de Tecnología Agropecuaria. Centro de Investigación en Ciencias Veterinarias y Agronómicas. Instituto de Virología; Argentina
Fil: Rocha, Lucia. Instituto Nacional de Tecnología Agropecuaria. Centro de Investigación en Ciencias Veterinarias y Agronómicas. Instituto de Virología; Argentina
Fil: Vega, Celina Guadalupe. Instituto Nacional de Tecnología Agropecuaria. Centro de Investigación en Ciencias Veterinarias y Agronómicas. Instituto de Virología e Innovaciones Tecnológicas. - Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Virología e Innovaciones Tecnológicas; Argentina
Fil: Rodriguez, Sergio A.. Massachusetts Institute of Technology; Estados Unidos
Fil: Dalvie, Neil C.. Massachusetts Institute of Technology; Estados Unidos
Fil: Tracey, Mary K.. Massachusetts Institute of Technology; Estados Unidos
Fil: Puntel, Mariana. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Instituto Nacional de Tecnología Agropecuaria. Centro de Investigación en Ciencias Veterinarias y Agronómicas. Instituto de Virología; Argentina
Fil: Wigdorovitz, Andrés. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Instituto Nacional de Tecnología Agropecuaria. Centro de Investigación en Ciencias Veterinarias y Agronómicas. Instituto de Virología; Argentina
Fil: Parreño, Gladys Viviana. Instituto Nacional de Tecnología Agropecuaria. Centro de Investigación en Ciencias Veterinarias y Agronómicas. Instituto de Virología e Innovaciones Tecnológicas. - Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Virología e Innovaciones Tecnológicas; Argentina
Fil: Love, Kerry R.. Massachusetts Institute of Technology; Estados Unidos
Fil: Cramer, Steven M.. Rensselaer Polytechnic Institute; Estados Unidos
Fil: Love, J. Christopher. Massachusetts Institute of Technology; Estados Unidos - Materia
-
INTEGRATED PURIFICATION
KOMAGATAELLA PHAFFII
PICHIA PASTORIS
SINGLE-DOMAIN ANTIBODIES
STRAIGHT-THROUGH CHROMATOGRAPHY
VHH - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/185008
Ver los metadatos del registro completo
id |
CONICETDig_d7845b51f1fd66c4c1c5837b5d6e29ec |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/185008 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Development of a platform process for the production and purification of single-domain antibodiesCrowell, Laura E.Goodwine, ChazSosa Holt, Carla SolangeRocha, LuciaVega, Celina GuadalupeRodriguez, Sergio A.Dalvie, Neil C.Tracey, Mary K.Puntel, MarianaWigdorovitz, AndrésParreño, Gladys VivianaLove, Kerry R.Cramer, Steven M.Love, J. ChristopherINTEGRATED PURIFICATIONKOMAGATAELLA PHAFFIIPICHIA PASTORISSINGLE-DOMAIN ANTIBODIESSTRAIGHT-THROUGH CHROMATOGRAPHYVHHhttps://purl.org/becyt/ford/2.10https://purl.org/becyt/ford/2Single-domain antibodies (sdAbs) offer the affinity and therapeutic value of conventional antibodies, with increased stability and solubility. Unlike conventional antibodies, however, sdAbs do not benefit from a platform manufacturing process. While successful production of a variety of sdAbs has been shown in numerous hosts, purification methods are often molecule specific or require affinity tags, which generally cannot be used in clinical manufacturing due to regulatory concerns. Here, we have developed a broadly applicable production and purification process for sdAbs in Komagataella phaffii (Pichia pastoris) and demonstrated the production of eight different sdAbs at a quality appropriate for nonclinical studies. We developed a two-step, integrated purification process without the use of affinity resins and showed that modification of a single process parameter, pH of the bridging buffer, was required for the successful purification of a variety of sdAbs. Further, we determined that this parameter can be predicted based only on the biophysical characteristics of the target molecule. Using these methods, we produced nonclinical quality sdAbs as few as 5 weeks after identifying the product sequence. Nonclinical studies of three different sdAbs showed that molecules produced using our platform process conferred protection against viral shedding of rotavirus or H1N1 influenza and were equivalent to similar molecules produced in Escherichia coli and purified using affinity tags.Fil: Crowell, Laura E.. Massachusetts Institute of Technology; Estados UnidosFil: Goodwine, Chaz. Rensselaer Polytechnic Institute; Estados UnidosFil: Sosa Holt, Carla Solange. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Instituto Nacional de Tecnología Agropecuaria. Centro de Investigación en Ciencias Veterinarias y Agronómicas. Instituto de Virología; ArgentinaFil: Rocha, Lucia. Instituto Nacional de Tecnología Agropecuaria. Centro de Investigación en Ciencias Veterinarias y Agronómicas. Instituto de Virología; ArgentinaFil: Vega, Celina Guadalupe. Instituto Nacional de Tecnología Agropecuaria. Centro de Investigación en Ciencias Veterinarias y Agronómicas. Instituto de Virología e Innovaciones Tecnológicas. - Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Virología e Innovaciones Tecnológicas; ArgentinaFil: Rodriguez, Sergio A.. Massachusetts Institute of Technology; Estados UnidosFil: Dalvie, Neil C.. Massachusetts Institute of Technology; Estados UnidosFil: Tracey, Mary K.. Massachusetts Institute of Technology; Estados UnidosFil: Puntel, Mariana. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Instituto Nacional de Tecnología Agropecuaria. Centro de Investigación en Ciencias Veterinarias y Agronómicas. Instituto de Virología; ArgentinaFil: Wigdorovitz, Andrés. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Instituto Nacional de Tecnología Agropecuaria. Centro de Investigación en Ciencias Veterinarias y Agronómicas. Instituto de Virología; ArgentinaFil: Parreño, Gladys Viviana. Instituto Nacional de Tecnología Agropecuaria. Centro de Investigación en Ciencias Veterinarias y Agronómicas. Instituto de Virología e Innovaciones Tecnológicas. - Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Virología e Innovaciones Tecnológicas; ArgentinaFil: Love, Kerry R.. Massachusetts Institute of Technology; Estados UnidosFil: Cramer, Steven M.. Rensselaer Polytechnic Institute; Estados UnidosFil: Love, J. Christopher. Massachusetts Institute of Technology; Estados UnidosJohn Wiley & Sons2021-02info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/185008Crowell, Laura E.; Goodwine, Chaz; Sosa Holt, Carla Solange; Rocha, Lucia; Vega, Celina Guadalupe; et al.; Development of a platform process for the production and purification of single-domain antibodies; John Wiley & Sons; Bioengineering And Biotechnology; 118; 9; 2-2021; 3348-33580006-3592CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/10.1002/bit.27724info:eu-repo/semantics/altIdentifier/doi/10.1002/bit.27724info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-10T13:25:08Zoai:ri.conicet.gov.ar:11336/185008instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-10 13:25:08.992CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Development of a platform process for the production and purification of single-domain antibodies |
title |
Development of a platform process for the production and purification of single-domain antibodies |
spellingShingle |
Development of a platform process for the production and purification of single-domain antibodies Crowell, Laura E. INTEGRATED PURIFICATION KOMAGATAELLA PHAFFII PICHIA PASTORIS SINGLE-DOMAIN ANTIBODIES STRAIGHT-THROUGH CHROMATOGRAPHY VHH |
title_short |
Development of a platform process for the production and purification of single-domain antibodies |
title_full |
Development of a platform process for the production and purification of single-domain antibodies |
title_fullStr |
Development of a platform process for the production and purification of single-domain antibodies |
title_full_unstemmed |
Development of a platform process for the production and purification of single-domain antibodies |
title_sort |
Development of a platform process for the production and purification of single-domain antibodies |
dc.creator.none.fl_str_mv |
Crowell, Laura E. Goodwine, Chaz Sosa Holt, Carla Solange Rocha, Lucia Vega, Celina Guadalupe Rodriguez, Sergio A. Dalvie, Neil C. Tracey, Mary K. Puntel, Mariana Wigdorovitz, Andrés Parreño, Gladys Viviana Love, Kerry R. Cramer, Steven M. Love, J. Christopher |
author |
Crowell, Laura E. |
author_facet |
Crowell, Laura E. Goodwine, Chaz Sosa Holt, Carla Solange Rocha, Lucia Vega, Celina Guadalupe Rodriguez, Sergio A. Dalvie, Neil C. Tracey, Mary K. Puntel, Mariana Wigdorovitz, Andrés Parreño, Gladys Viviana Love, Kerry R. Cramer, Steven M. Love, J. Christopher |
author_role |
author |
author2 |
Goodwine, Chaz Sosa Holt, Carla Solange Rocha, Lucia Vega, Celina Guadalupe Rodriguez, Sergio A. Dalvie, Neil C. Tracey, Mary K. Puntel, Mariana Wigdorovitz, Andrés Parreño, Gladys Viviana Love, Kerry R. Cramer, Steven M. Love, J. Christopher |
author2_role |
author author author author author author author author author author author author author |
dc.subject.none.fl_str_mv |
INTEGRATED PURIFICATION KOMAGATAELLA PHAFFII PICHIA PASTORIS SINGLE-DOMAIN ANTIBODIES STRAIGHT-THROUGH CHROMATOGRAPHY VHH |
topic |
INTEGRATED PURIFICATION KOMAGATAELLA PHAFFII PICHIA PASTORIS SINGLE-DOMAIN ANTIBODIES STRAIGHT-THROUGH CHROMATOGRAPHY VHH |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/2.10 https://purl.org/becyt/ford/2 |
dc.description.none.fl_txt_mv |
Single-domain antibodies (sdAbs) offer the affinity and therapeutic value of conventional antibodies, with increased stability and solubility. Unlike conventional antibodies, however, sdAbs do not benefit from a platform manufacturing process. While successful production of a variety of sdAbs has been shown in numerous hosts, purification methods are often molecule specific or require affinity tags, which generally cannot be used in clinical manufacturing due to regulatory concerns. Here, we have developed a broadly applicable production and purification process for sdAbs in Komagataella phaffii (Pichia pastoris) and demonstrated the production of eight different sdAbs at a quality appropriate for nonclinical studies. We developed a two-step, integrated purification process without the use of affinity resins and showed that modification of a single process parameter, pH of the bridging buffer, was required for the successful purification of a variety of sdAbs. Further, we determined that this parameter can be predicted based only on the biophysical characteristics of the target molecule. Using these methods, we produced nonclinical quality sdAbs as few as 5 weeks after identifying the product sequence. Nonclinical studies of three different sdAbs showed that molecules produced using our platform process conferred protection against viral shedding of rotavirus or H1N1 influenza and were equivalent to similar molecules produced in Escherichia coli and purified using affinity tags. Fil: Crowell, Laura E.. Massachusetts Institute of Technology; Estados Unidos Fil: Goodwine, Chaz. Rensselaer Polytechnic Institute; Estados Unidos Fil: Sosa Holt, Carla Solange. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Instituto Nacional de Tecnología Agropecuaria. Centro de Investigación en Ciencias Veterinarias y Agronómicas. Instituto de Virología; Argentina Fil: Rocha, Lucia. Instituto Nacional de Tecnología Agropecuaria. Centro de Investigación en Ciencias Veterinarias y Agronómicas. Instituto de Virología; Argentina Fil: Vega, Celina Guadalupe. Instituto Nacional de Tecnología Agropecuaria. Centro de Investigación en Ciencias Veterinarias y Agronómicas. Instituto de Virología e Innovaciones Tecnológicas. - Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Virología e Innovaciones Tecnológicas; Argentina Fil: Rodriguez, Sergio A.. Massachusetts Institute of Technology; Estados Unidos Fil: Dalvie, Neil C.. Massachusetts Institute of Technology; Estados Unidos Fil: Tracey, Mary K.. Massachusetts Institute of Technology; Estados Unidos Fil: Puntel, Mariana. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Instituto Nacional de Tecnología Agropecuaria. Centro de Investigación en Ciencias Veterinarias y Agronómicas. Instituto de Virología; Argentina Fil: Wigdorovitz, Andrés. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Instituto Nacional de Tecnología Agropecuaria. Centro de Investigación en Ciencias Veterinarias y Agronómicas. Instituto de Virología; Argentina Fil: Parreño, Gladys Viviana. Instituto Nacional de Tecnología Agropecuaria. Centro de Investigación en Ciencias Veterinarias y Agronómicas. Instituto de Virología e Innovaciones Tecnológicas. - Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Virología e Innovaciones Tecnológicas; Argentina Fil: Love, Kerry R.. Massachusetts Institute of Technology; Estados Unidos Fil: Cramer, Steven M.. Rensselaer Polytechnic Institute; Estados Unidos Fil: Love, J. Christopher. Massachusetts Institute of Technology; Estados Unidos |
description |
Single-domain antibodies (sdAbs) offer the affinity and therapeutic value of conventional antibodies, with increased stability and solubility. Unlike conventional antibodies, however, sdAbs do not benefit from a platform manufacturing process. While successful production of a variety of sdAbs has been shown in numerous hosts, purification methods are often molecule specific or require affinity tags, which generally cannot be used in clinical manufacturing due to regulatory concerns. Here, we have developed a broadly applicable production and purification process for sdAbs in Komagataella phaffii (Pichia pastoris) and demonstrated the production of eight different sdAbs at a quality appropriate for nonclinical studies. We developed a two-step, integrated purification process without the use of affinity resins and showed that modification of a single process parameter, pH of the bridging buffer, was required for the successful purification of a variety of sdAbs. Further, we determined that this parameter can be predicted based only on the biophysical characteristics of the target molecule. Using these methods, we produced nonclinical quality sdAbs as few as 5 weeks after identifying the product sequence. Nonclinical studies of three different sdAbs showed that molecules produced using our platform process conferred protection against viral shedding of rotavirus or H1N1 influenza and were equivalent to similar molecules produced in Escherichia coli and purified using affinity tags. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-02 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/185008 Crowell, Laura E.; Goodwine, Chaz; Sosa Holt, Carla Solange; Rocha, Lucia; Vega, Celina Guadalupe; et al.; Development of a platform process for the production and purification of single-domain antibodies; John Wiley & Sons; Bioengineering And Biotechnology; 118; 9; 2-2021; 3348-3358 0006-3592 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/185008 |
identifier_str_mv |
Crowell, Laura E.; Goodwine, Chaz; Sosa Holt, Carla Solange; Rocha, Lucia; Vega, Celina Guadalupe; et al.; Development of a platform process for the production and purification of single-domain antibodies; John Wiley & Sons; Bioengineering And Biotechnology; 118; 9; 2-2021; 3348-3358 0006-3592 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/10.1002/bit.27724 info:eu-repo/semantics/altIdentifier/doi/10.1002/bit.27724 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
John Wiley & Sons |
publisher.none.fl_str_mv |
John Wiley & Sons |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842981395100598272 |
score |
12.48226 |